BioSpace · Feb 2026
Described the company’s updated at-home blood testing and health-tracking platform and its mission to make testing easier and more accessible from home.
Wearable and At-Home protein monitoring with silicon photonic chips
Public company, workplace, funding, and market signals
Burlington, MA at-home blood testing and health optimization company founded in 2020 by MIT scientists Michael Dubrovsky and Diedrik Vermeulen. SiPhox combines EasyDraw home collection, CLIA/CAP lab processing, silicon-photonics hardware, and AI-driven insights to help consumers and partners monitor cardiovascular, metabolic, hormonal, thyroid, inflammatory, and related biomarkers.
Primary product
At-home blood testing platform with EasyDraw and SiPhox Home/One hardware
Founded
2020
Headquarters
111 Terrace Hall Ave, Burlington, MA 01803, United States
Team size
50-60
Industry
Consumer Services
Sub-industry
At-home health diagnostics / blood biomarker testing
Offices
0 jobs at SiPhox Health
Check back later for new openings
Business model
Stage
Series A
Total raised
$35.4M
Latest round
Series A - III
Leadership
Co-founder and CEO
Founder and Chief Commercial Officer
Chief Financial Officer
Chief Operating Officer
Director of Chips and Sensors
Director of Clinical Product Operations
Director of Biomedical Integration
Aliya Mackenzie, MD
Health Programs Lead
Daniel Kaplan, PhD
Director of Assay Development
Mission-driven preventive-health company blending biotech, software, and photonics; emphasizes health optimization, convenience, transparency, and a distributed Boston/Ljubljana team.
Compensation
Public job-board signals show roughly $80k-$160k base ranges for some roles, while Glassdoor reviews suggest base pay is not top-of-market but equity upside helps offset it.
Benefits
Pricing
Membership subscription with configurable monthly, quarterly, or semiannual cadence; base pricing starts around $124-$125 per cycle plus shipping, with paid panel add-ons and an Ultimate 360 upgrade.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Estimated monthly visits
180.5K
Traffic estimate as of Jun 2026
BioSpace · Feb 2026
Described the company’s updated at-home blood testing and health-tracking platform and its mission to make testing easier and more accessible from home.
Insider / Fitt · Jun 2025
Announced Sai, the AI-powered lab test analyzer integrated into SiPhox’s dashboard, and described the product as a way to parse outside lab reports and surface personalized insights.
Boston Globe · Feb 2025
Profiled the Burlington company, its in-home blood-testing roadmap, its founding in 2020, and its venture backing from Y Combinator, Intel Capital, and Khosla Ventures.
MIT News · Nov 2024
Explained the silicon-photonic chip, the current mail-in blood testing business, and the company’s goal of enabling home-based biomarker testing at scale.
TechCrunch · Jul 2023
Covered the $27M raise, the split between seed and Series A capital, investor participation, and the company’s plans for FDA clearance and at-home diagnostic hardware.